Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 1,202.00
-18.00 (-1.48%)
At close: Feb 6, 2026
Kohjin Bio Market Cap
Kohjin Bio has a market cap or net worth of 6.14 billion as of February 6, 2026. Its market cap has decreased by -24.54% in one year.
Market Cap
6.14B
Enterprise Value
5.51B
Revenue
5.20B
Ranking
n/a
PE Ratio
8.55
Stock Price
1,202.00
Market Cap Chart
Since April 25, 2024, Kohjin Bio's market cap has decreased from 11.89B to 6.14B, a decrease of -48.31%. That is a compound annual growth rate of -30.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 6.14B | -19.27% |
| Dec 30, 2025 | 7.61B | -11.16% |
| Dec 30, 2024 | 8.57B | -27.92% |
| Apr 25, 2024 | 11.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chiome Bioscience | 7.73B |
| BrightPath Biotherapeutics | 7.68B |
| OncoTherapy Science | 7.53B |
| Linical | 7.09B |
| PRISM BioLab Co.,LTD | 6.87B |
| TMS Co., Ltd. | 6.46B |
| Noile-Immune Biotech | 6.45B |
| Soiken Holdings | 6.43B |